The asymmetric Hopfield model is used to simulate signaling dynamics in gene/transcription factor networks. The model allows for a direct mapping of a gene expression pattern into attractor states. We analyze different control strategies aiming at disrupting attractor patterns using selective local fields representing therapeutic interventions. The control strategies are based on the identification of signaling bottlenecks, which are single nodes or strongly connected clusters of nodes that have a large impact on the signaling. We provide a theorem with bounds on the minimum number of nodes that guarantee controllability of bottlenecks consisting of strongly connected components. The control strategies are applied to the identification of sets of proteins that, when inhibited, selectively disrupt the signaling of cancer cells while preserving the signaling of normal cells. We use an experimentally validated non-specific network and a specific B cell interactome reconstructed from gene expression data to model cancer signaling in lung and B cells, respectively. This model could help in the rational design of novel robust therapeutic interventions based on our increasing knowledge of complex gene signaling networks.
The asymmetric Hopfield model is used to simulate signaling dynamics in gene/transcription factor networks. The model allows for a direct mapping of a gene expression pattern into attractor states. We analyze different control strategies aiming at disrupting attractor patterns using selective local fields representing therapeutic interventions. The control strategies are based on the identification of signaling bottlenecks, which are single nodes or strongly connected clusters of nodes that have a large impact on the signaling. We provide a theorem with bounds on the minimum number of nodes that guarantee controllability of bottlenecks consisting of strongly connected components. The control strategies are applied to the identification of sets of proteins that, when inhibited, selectively disrupt the signaling of cancer cells while preserving the signaling of normal cells. We use an experimentally validated non-specific network and a specific B cell interactome reconstructed from gene expression data to model cancer signaling in lung and B cells, respectively. This model could help in the rational design of novel robust therapeutic interventions based on our increasing knowledge of complex gene signaling networks. 
I. INTRODUCTION
The vision behind systems biology is that complex interactions and emergent properties determine the behavior of biological systems. Many theoretical tools developed in the framework of spin glass models are well suited to describe emergent properties, and their application to large biological networks represents an approach that goes beyond pinpointing the behavior of a few genes or metabolites in a pathway. The Hopfield model [1] is a spin glass model that was introduced to describe neural networks, and that is solvable using mean field theory [2] . The asymmetric case, in which the interaction between the spins can be seen as directed, can also be exacty solved in some limits [3] . The model belongs to the class of attractor neural networks, in which the spins evolve towards stored attractor patterns, and it has been used to model biological processes of high current interest, such as the reprogramming of pluripotent stem cells [4] . Moreover, it has been suggested that a biological system in a chronic or therapy-resistant disease state can be seen as a network that has become trapped in a pathological Hopfield attractor [5] . A similar class of models is represented by Random Boolean Networks [6] , which were proposed by Kauffman to describe gene regulation and expression states in cells [7] . Differences and similarities between the Kauffman-type and Hopfield-type random networks have been studied for many years [8] [9] [10] [11] .
In this paper, we consider an asymmetric Hopfield model built from realistic (even if incomplete [12, 13] ) cellular networks, and we map the spin attractor states to gene expression data from normal and cancer cells. We will focus on the question of the control of the dynamical properties of the network using external local fields representing therapeutic interventions. To a major extent, the final determinant of cellular phenotype is the expression and activity pattern of all proteins within the cell, which is related to levels of mRNA transcripts. Microarrays measure genome-wide levels of mRNA expression that therefore can be considered a rough snapshot of the state of the cell. This state is relatively stable, reproducible, unique to cell types, and can differentiate cancer cells from normal cells, as well as differentiate between different types of cancer [14, 15] . In fact, there is evidence that attractors exist in gene expression states, and that these attractors can be reached by different trajectories rather than only by a single transcriptional program [16] . While the dynamical attractors paradigm has been originally proposed in the context of cellular developement, the similarity between cellular ontogenesis, i.e. the developement of different cell types, and oncogenesis, i.e. the process under which normal cells are transformed into cancer cells, has been recently emphasized [17] . The main hypothesis of this paper is that cancer robustness is rooted in the dynamical robustness of signaling in an underlying cellular network. If the cancerous state of rapid, uncontrolled growth is an attractor state of the system [18] , a goal of modeling therapeutic control could be to design complex therapeutic interventions based on drug combinations [19] that push the cell out of the cancer attractor basin. [20] Many authors have discussed the control of biological signaling networks using complex external perturbations. Calzolari and coworkers considered the effect of complex external signals on apoptosis signaling [21] . Agoston and coworkers [22] suggested that perturbing a complex biological network with partial inhibition of many targets could be more effective than the complete inhibition of a single target, and explicitly discussed the implications for multi-drug therapies [23] . In the traditional approach to control theory [24] , the control of a dynamical system consists in finding the specific input temporal se-quence required to drive the system to a desired output. This approach has been discussed in the context of Kauffmann Boolean networks [25] and their attractor states [26] . Several studies have focused on the intrinsic global properties of control and hierarchical organization in biological networks [27, 28] . A recent study has focused on the minimum number of nodes that needs to be addressed to achieve the complete control of a network [29] . This study used a linear control framework, a matching algorithm [30] to find the minimum number of controllers, and a replica method to provide an analytic formulation consistent with the numerical study. Finally, Cornelius et al. [31] discussed how nonlinearity in network signaling allows reprogrammig a system to a desired attractor state even in the presence of contraints in the nodes that can be accessed by external control. This novel concept was explicitly applied to a T-cell survival signaling network to identify potential drug targets in T-LGL leukemia. The approach in the present paper is based on nonlinear signaling rules and takes advantage of some useful properties of the Hopfield formulation. In particular, by considering two attractor states we will show that the network separates into two types of domains which do not interact with each other. Moreover, the Hopfield framework allows for a direct mapping of a gene expression pattern into an attractor state of the signaling dynamics, facilitating the integration of genomic data in the modeling.
The paper is structured as follows. In Section II we summarize the model and review some of its key properties. Section III describes general strategies aiming at selectively disrupting the signaling only in cells that are near a cancer attractor state. The strategies we have investigated use the concept of bottlenecks, which identify single nodes or strongly connected clusters of nodes that have a large impact on the signaling. In this section we also provide a theorem with bounds on the minimum number of nodes that guarantee controllability of a bottleneck consisting of a strongly connected component. This theorem is useful for practical applications since it helps to establish whether an exhaustive search for such minimal set of nodes is practical. In Section IV we apply the control strategies of Section III to lung and B cell cancers. We will use two different networks for this analysis. The first is an experimentally validated and nonspecific network obtained from a kinase interactome and phospho-protein database [32] combined with a database of interactions between transcription factors and their target genes [33] . The second network is cell-specific and was obtained using network reconstruction algorithms and transcriptional and post-translational data from mature human B cells [34] . The algoritm reconstructed network is significantly more dense than the experimental one, and the same control strategies produce different results in the two cases. Conclusions are in Section V.
II. MODEL
We define the adjacency matrix of a network G as
where j → i denotes a directed edge from node j to node i. The set of nodes in the network G is indicated by V (G) and the set of ordered pairs by E(G) = {(j, i) : j → i}.
In our analysis we assume that G is given. The spin of node i at time t is σ i (t) = ±1, and indicates an expresssed (+1) or not expressed (−1) gene. We encode an arbitrary attractor state ξ = (ξ 1 , ξ 2 , ..., ξ N ), with ξ i = ±1 by defining the coupling matrix
The total field at node i is then
is the external field applied to node i, which will be discussed below. The discrete-time update scheme is defined as
(3) where T ≥ 0 is an effective temperature. For the remainder of the paper, we consider the case of T = 0 so that σ i = sign(h i ), and the spin is chosen randomly from ±1 if h i = 0. For convenience, we take t ∈ Z and ∆t = 1. Nodes can be updated synchronously, and synchronous updating can lead to limit cycles in our model [9] . Nodes can also be updated separately and in random order (anynchronous updating), which does not result in limit cycles. All results presented in this paper use the synchronous update scheme.
Some nodes may have no incoming connections. According to Eq. (3), these source nodes flip randomly between +1 and −1. The sources are thus fixed to their initial states so that σ q (t) = σ q (0) for all q ∈ Q, where Q is the set of source nodes. The source nodes flip if directly targeted by an external field. Biologically, genes at the "top" of a network are assumed to be controlled by elements outside of the network.
In application, two attractors are needed. Define these states as ξ n and ξ c , the normal state and cancer state, respectively. The magnetization along attractor state a is
where N is the number of nodes in the network. Note that if m a (t) = ±1, σ(t) = ± ξ a . We also define the steady state magnetization along state a as
i . We also define the set of similarity nodes S = {i : ξ Connections between two similarity nodes or two differential nodes remain in the network, whereas connections that link nodes of different types transmit no signals. The effective deletion of edges between nodes means that the original network fully separates into two subnetworks: one composed entirely of similarity nodes (the similarity network ) and another composed entirely of differential nodes (the differential network ), each of which can be composed of one or more separate weakly connected components (see Fig. 1 ). With this separation, new source nodes (effective sources) can be exposed in both the similarity and differential networks. For the remainder of this article, Q is the set of both source and effective source nodes in a given network. For p = 2, every edge that connects a similarity node to a differential node or a differential node to a similarity node transmits no signal. Thus, the signaling in the right network shown above is identical to that of the left network. Because the goal is to leave normal cells unaltered while damaging cancer cells as much as possible, all similarity nodes can be safely ignored, and searches and simulations only need to be done on the differential subnetwork.
III. CONTROL STRATEGIES
The optimal choice of control strategy depends on the control goals, the network topology, the effective topology created by the attractor states, and the set of directly controllable nodes. The strategies presented below focus on selecting the best single nodes or small clusters of nodes to control, ranked by how much they individually change m a ∞ . In application, however, controlling many nodes is necessary to achieve a sufficiently changed m a ∞ . The effects of controlling a set of nodes can be more than the sum of the effects of controlling individual nodes, and predicting the truly optimal set of nodes to target is computationally difficult. Here, we discuss heuristic strategies for controlling large networks where the combinatorial approach is impractical.
For both p = 1 and p = 2, simulating a cancer cell means that σ(0) = + ξ c , and likewise for normal cells. Although the normal and cancer states are mathematically interchangeable, biologically we seek to decrease m c ∞ as much as possible while leaving m n ∞ ≈ +1. By "network control" we thus mean driving the system away from its initial state of σ(0) = ξ c with h ext . Controlling individual nodes is achieved by applying an infinitely strong field to a set of targeted nodes T so that
This ensures that the drug field can always overcome the field from neighboring nodes. In application, similarity nodes are never deliberately directly targeted, since changing their state would adversely affect both normal and cancer cells. Roughly 70% of the nodes in the networks surveyed are similarity nodes, so the search space is reduced. For p = 2, the effective edge deletion means that only the differential network in cancer cells needs to be simulated to determine the effectiveness of h ext . For p = 1, however, there may be some similarity nodes that receive signals from upstream differential nodes. In this case, the full effect of h ext can be determined only by simulating all differential nodes as well as any similarity nodes downstream of differential nodes. All following discussion assumes that all nodes examined are differential, and therefore targetable, for both p = 1 and p = 2. The existence of similarity nodes for p = 1 only limits the set of targetable nodes.
A. Directed acyclic networks
Full control of a directed acyclic network is achieved by forcing σ q = −ξ c q for all q ∈ Q. This guarantees m c ∞ = −1. Suppose that nodes q ∈ Q in an acyclic network have always been fixed away from the cancer state, that is,
Because there are no cycles present, all upstream paths of sufficent length terminate at a source. Because the spin of all nodes q ∈ Q point away from the cancer attractor state, all nodes downstream must also point away from the cancer attractor state. Thus, for acyclic networks, forcing
The complications that arise from cycles are discussed in the next subsection. However, controlling the original and effective sources may not be the most efficient way to push the system away from the cancer basin of attraction and, depending on the control limitations, it may not be possible. If minimizing the number of controllers is required, searching for the most important bottlenecks is a better strategy.
Consider a directed network G and an initially identical copy, G ′ = G. If removing node i (and all connections to and from i) from G ′ decreases the indegree of at least one node j ∈ V (G ′ ), j = i, to less than half of its indegree in network G, {i} is a size 1 bottleneck. The bottleneck control set of bottleneck {i}, L(i), is defined algorithmically as follows: (1) Begin a set L(i) with the current bottleneck i so that L = {i}; (2) Remove bottleneck {i} from network G ′ ; (3) Append L(i) with all nodes j with current indegree that is less than half of that from the original network G; (4) Remove all nodes j from the network G ′ . If additional nodes in G ′ have their indegree reduced to below half of their indegree in G, go to step 3. Otherwise, stop. The impact of the bottleneck i, I(i), is defined as
where |X| is the cardinality of the set X. The impact of a bottleneck is the minimum number of nodes that are guaranteed to switch away from the cancer state when the bottleneck is forced away from the cancer state. The impact is used to rank the size 1 bottlenecks by importance, with the most important as those with the largest impact. In application, when searching for nodes to control, any size 1 bottleneck {i} that appears in the bottleneck control set of a different size 1 bottleneck {j} can be ignored, since fixing j to the normal state fixes i to the normal state as well. Note that the definition given above in terms of G and G ′ avoids miscounting in the impact of a bottleneck. The network in Fig. 2 , for example, has three sources (nodes 1, 2 and 3), but one important bottleneck (node 6). If full damage, i.e. m c ∞ = −1, is required, then control of all source nodes is necessary. If minimizing the number of directly targeted nodes is important and m c ∞ > −1 can be tolerated, then control of the bottleneck node 6 is a better choice.
B. Directed cycle-rich networks
Not all networks can be fully controlled at T = 0 by controlling the source nodes, however. If there is a cycle present, paths of infinite length exist and the final state of the system may depend on the initial state, causing parts of the network to be hysteretic. Controlling only sources in a general directed network thus does not guarantee m The only way to indirectly control nodes 8-10 is to target nodes inside of the cycle cluster. Targeting node 4, 6 or 7 will cause the entire cycle cluster to flip away from its initial state, guaranteeing control of nodes 4-10 (see Fig. 4 ).
nodes downsteam of node 3 (see Fig. 4 ). This is because the indegree deg − (4) = 4, and a majority of the nodes connecting to node 4 are in the cancer attractor state. At T = 0, cycle clusters with high connectivity tend to block incoming signals from outside of the cluster, resulting in an insurmountable activation barrier.
The most effective single node to control in this network is any one of nodes 4, 6 or 7. Forcing any of these away from the cancer attractor state will eventually cause the entire cycle cluster to flip away from the cancer state, and all nodes downstream will flip as well, as shown in Fig. 4 . The cycle cluster here acts as a sort of large, hysteretic bottleneck. We now generalize the concept of bottlenecks.
Define a size k bottleneck in a network G to be a cycle cluster B with |V (B)| = k which, when removed from G, reduces the indegree of at least one node j ∈ V (G), j ∈ V (B) to less than half of its original indegree. Other than now using the set of nodes V (B) rather than a single node set, the above algorithm for finding the bottleneck control set remains unchanged. In Fig. 3 , for instance, V (B) = {4, 5, 6, 7}, k = 4, L(B) = {4, 5, 6, 7, 8, 9, 10}, and I(B) = 7. With this more general definition, we note that controlling any size k bottleneck B guarantees control of all size 1 bottlenecks B ′ in the control set of B for all k ≥ 1.
For any bottleneck B of size k ≥ 1 in a network G, define the set of critical nodes, Z(B, G), as the set of nodes Z(B, G) ⊆ V (B) of minimum cardinality that, when controlled, guarantees full control of all nodes i ∈ V (B). Also define the critical number of nodes as n crit (B, G) = |Z(B, G)|. Thus, for the network in Fig. 4 , Z(B, G) = {4}, {6}, or {7}, and n crit (B, G) = 1. In general, however, more than one node in a cycle cluster may need to be targeted to control the entire cycle cluster. Fig. 5 shows a cycle cluster (composed of nodes 2-10) that cannot be controlled by targeting any single node. The precise value of n crit for a given cycle cluster C depends on its topology as well as the edges connecting nodes from outside of C to the nodes inside of C, and finding Z(C, G) can be difficult. We present a theorem that puts bounds on n crit to help determine whether a search for Z(C, G) is practical.
Theorem: Suppose a network G contains a cycle cluster C. Define the set of externally influenced nodes
the set of intruder connections
and the reduced set of critical nodes
If N = |V (C)| and
where deg
where
Proof: First, prove the lower limit of Eq. (18) . Let C be a cycle cluster in a network G with R(C, G) = {∅}. (A cycle cluster in a network with |R(C, G)| > 0 will have the same or higher activation barrier for any node in the cluster than the same cycle cluster in a network with R = {∅}. Since we are examining the lower limit of Eq. (18), we consider the case with the lowest activation barrier. Any externally influenced nodes cause n crit to either increase or remain the same.) For any node i to be able to flip away from the cancer state (although not necessarily remain there), we must have that h i = −aξ c i for a ≥ 0, meaning that at least half of the nodes upstream of i must point away from the cancer state. The node i requiring the smallest number of upstream nodes to be in the normal state is the node that satisfies deg − (i) = µ. Controlling less than µ/2 nodes will leave all uncontrolled nodes with a field in the cancer direction, and no more flips will occur. Thus,
For the upper limit of Eq. (18), consider a complete clique on N nodes, C = K N (that is, A ij = 1 for all i, j ∈ V (K N ), including self loops) in a network G. First, let there be no connections to any nodes in C from outside of C so that R(C, G) = {∅}. For odd N , forcing (N + 1)/2 nodes away from the cancer state will result in the field
for all nodes i. After one time step, all nodes will flip away from the cancer state. For even N , forcing N/2 nodes away from the cancer state will result in the field
for all nodes i. At the next time step, the unfixed nodes will pick randomly between the normal and cancer state. If at least one of these nodes makes the transition away from the cancer state, the field at all other nodes will point away from the cancer direction. The system will then require one more time step to completely settle to
K N with σ i (0) = ξ c i gives the largest activation barrier for any cycle cluster on N nodes with R(C, G) = {∅} to switch away from the cancer attractor state. A general cycle cluster C with any topology on N nodes with R(C, G) = {∅} in a network G will have deg − (i) ≤ N for all nodes i, and so we have the upper bound
thus proving Eq. (18) for the special case of R(C, G) = {∅}. Now consider a cycle cluster C on N nodes in a network G with |R(C, G)| ≥ 0. Suppose all nodes in Z red (C, G) are fixed away from the cancer state. By Eq. (24) ,
i is guaranteed because it has already been directly controlled. Any node i ∈ (R(C, G) \ Z red (C, G)) has some incoming connections from nodes j / ∈ V (C), and these connections could increase the activation barrier enough such that fixing Z red (C, G) is not enough to guarantee σ i (t → ∞) = −ξ c i . To ensure that any node l ∈ V (C) points away from the cancer state, it is sufficient to fix all nodes i ∈ (R(C, G) \ Z red (C, G)) as well as Z red (C, G) away from the cancer state. This increases n crit by at most |R(C, G) \ Z red (C, G)|, leaving
n crit can never exceed N , however, because directly controlling every node results in controlling C. We can thus say that There can be more than one Z red for a given cycle cluster. Note that the tightest constraints on n crit in Eq. (18) come from using the Z red with the largest overlap with R. If finding Z red is too difficult, an overestimate for the upper limit of n crit can be made by assuming that R ∩ Z red = {∅} so that
(27) The cycle cluster in Fig. 5 has N = 9, R = {2, 9}, µ = 1, and one of the reduced sets of critical nodes is Z red = {9, 10}, so 1 ≤ n crit ≤ 6. It can be shown through an exhaustive search that for this network n crit = 2, and the set of critical nodes is Z = {9, 10} (see Fig. 6 ). Here, Z = Z red , although this is not always the case. Because the cycle cluster has 9 nodes and 1 ≤ n crit ≤ 6, at most 6 n=1 9 n = 465 simulations are needed to find at least one solution for Z(C, G). However, the maximum number of simulations required to find Z(C, G) increases exponentially and for larger networks the problem quickly becomes intractable.
One heuristic strategy for controlling cycle clusters is to look for size k ′ < |V (C)| bottlenecks inside of C. Bottlenecks of size k ≫ 1 and average indegree deg − (B) ≪ k can contain high impact size k ′ bottlenecks, where k ′ < k. Size k ≥ 1 bottlenecks need to be compared to find the best set of nodes to target to reduce m c ∞ . Simply comparing the impact is insufficent because a cycle cluster with a large impact could also have a large n crit , requiring much more effort than its impact merits. Define the critical efficiency of a bottleneck B as
If the critical efficiency of a cycle cluster is much smaller than the impacts of size 1 bottlenecks from outside of the cycle cluster, the the cycle cluster can be safely ignored.
For some cycle clusters, however, not all of the nodes need to be controlled in order for a large portion of the nodes in the cycle cluster's control set to flip. Define the optimal efficiency of a bottleneck B as e opt (B) = max n=1,2,...
where B i ∈ V (B) are size 1 bottlenecks and I(B i ) > I(B i+1 ) for all i. Note that for any size 1 bottleneck B, e opt (B) = e crit (B) = I(B). This quantity thus allows bottlenecks with very different properties (I(B), n crit (B, G), or |V (B)|) to be ranked against each other. All strategies presented above are designed to select the best individual or small group of nodes to target. Significant changes in the biological networks' magnetization require targeting many nodes, however. Brute force searches on the effect of larger combinations of nodes are typically impossible because the required number of simulations scales exponentially with the number of nodes. A crude Monte Carlo search is also numerically expensive, since it is difficult to sample an appreciable portion of the available space. Our alternative is to take advanatge of the bottleneck nodes that can be easily found, and rank all size k ≥ 1 bottlenecks B i in an ordered list U such that
for all B i , B j ∈ U and fix the bottlenecks in the list in order. This is called the efficiency-ranked strategy. If all size k > 1 bottlenecks are ignored, it is called the pure efficiency-ranked strategy, and if size k > 1 bottlenecks are included it is called the mixed efficiency-ranked strategy. An effective polynomial-time algorithm for finding the top z nodes to fix, which we call the best+1 strategy (equivalent to a greedy algorithm), works as follows: (1) Begin with a seed set of nodes to fix, F ; (2) Test the effect of fixing F ∪ i for all allowed nodes i / ∈ F ; (3) F ← F ∪ i best , where i best is the best node from all i sampled; (4) If |F | < z, go to step (2). Otherwise, stop. The seed set of nodes could be the single highest impact size 1 bottleneck in the network, or it could be the best set of n nodes (where n < z) found from a brute force search.
IV. CANCER SIGNALING
In application to biological systems, we assume that the magnetization of cell type a is related to the viability of cell type a, that is, the fraction of cells of type a that survives a drug treatment. It is reasonable to assume We need to use as few controllers as possible to sufficiently reduce m c ∞ while leaving m n ∞ ≈ +1. In practical applications, however, one is limited in the set of druggable targets. All classes of drugs are constrained to act only on a specific set of biological components. For example, one class of drugs that is currently under intense research is protein kinase inhibitors [36] . In this case one has two constraints: the only nodes that can be targeted are those that correspond to kinases, and they can only be inhibited, i.e. turned off. We will use the example of kinase inhibitors to show how controllability is affected by such type of constraints. In the real systems studied, many differential nodes have only similarity nodes upstream and downstream of them, while the remaining differential nodes form one large cluster. This is not important for p = 1, but the effective edge deletion for p = 2 results in many islets, which are nodes i with A ij = A ji = 0 for all i = j (self-loops allowed). Controlling islets requires targeting each islet individually. For p = 2, we concentrate on controlling only the largest weakly connected differential subnetwork. All final magnetizations are normalized by the total number of nodes in the full network, even if the simulations are only conducted on small portion of the network.
A. Lung cell network
The network used to simulate lung cells was built by combining the kinase interactome from Phospho-POINT [32] with the transcription factor interactome from TRANSFAC [33] . Both of these are general networks that were constructed by compiling many observed pairwise interactions between components, meaning that if j → i, at least one of the proteins encoded by gene j has been directly observed interacting with gene i in experiments. This bottom-up approach means that some edges may be missing, but those present are reliable. Because of this, the network is sparse (∼ 0.057% complete, see Table I), resulting in the formation of many islets for p = 2. Note also that this network presents a clear hierarchical structure, characteristic of biological networks [37, 38] , with many "sink" nodes [39] that are targets of transcription factors and a relatively large cycle cluster originating from the kinase interactome. In our signaling model, the IMR-90 cell line was used for the normal attractor state, and the two cancer attractor states examined were from the A549 (adenocarcinoma) and NCI-H358 (bronchioalveolar carcinoma) cell lines. The resulting magnetization curves for A549 and NCI-H358 are very similar, so the following analysis addresses only A549. Table II  lists There is one important cycle cluster in the full network, and it is composed of 401 nodes. This cycle cluster has an impact of 7948 for p = 1, giving a critical efficiency of at least ∼ 19.8, and 1 ≤ n crit ≤ 401 by Eq. 27. The optimal efficiency for this cycle cluster is e opt = 29, but this is achieved for fixing the first bottleneck in the cluster. Additionally, this node is the highest impact size 1 bot- Nodes  506  667  684  511  841  621  457  742  Edges  846  1227  2855  1717  3962  2525  1501  3401  Sources and effective sources  30  34  12  11  9  9  9  12  Sinks and effective sinks  450  598  286  198  369  275 tleneck in the full network, and so the mixed efficiencyranked results are identical to the pure efficiency-ranked results for the unconstrained p = 1 lung network. The mixed efficiency-ranked strategy was thus ignored in this case. Fig. 7 shows the results for the unconstrained p = 1 model of the IMR-90/A549 lung cell network [40] . The unconstrained p = 1 system has the largest search space, so the Monte Carlo strategy performs poorly. The best+1 strategy is the most effective strategy for controlling this network. The seed set of nodes used here was simply the size 1 bottleneck with the largest impact. Note that best+1 works better than effeciency-ranked. This is becasue best+1 includes the synergistic effects of fixing multiple nodes, while efficiency-ranked assumes that there is no overlap between the set of nodes downstream from multiple bottlenecks. Importantly, however, the efficiency-ranked method works nearly as well as best+1 and much better than Monte Carlo, both of which are more computationally expensive than the efficiencyranked strategy. Fig. 8 shows the results for the unconstrained p = 2 model of the IMR-90/A549 lung cell network. The search space for p = 2 is much smaller than that for p = 1. The largest weakly connected differential subnetwork contains only 506 nodes (see Table III ) , and the remaining differential nodes are islets or are in subnetworks composed of two nodes and are therefore unnecessary to consider. Of these 506 nodes, 450 are sinks. If limiting the search to differential kinases with ξ c i = +1 and ignoring all sinks, p = 2 has 19 possible targets. There is only one cycle cluster in the largest differential subnetwork, containing 6 nodes. Like the p = 1 case, the optimal efficiency occurs when targeting the first node, which is the highest impact size 1 bottleneck. Because the mixed efficiency-ranked strategy gives the same results as the Final cancer magnetizations for an unconstrained search on the lung cell network using p = 1. The efficiencyranked strategy outperforms the relatively expensive Monte Carlo strategy. The best+1 strategy works best, although it requires the largest computational time. Note that the mixed efficiency-ranked curve is not shown because it is identical to the pure efficiency-ranked curve. Key: MC = Monte Carlo, B+1 = best+1, ERP = pure efficiency-ranked, ERM = mixed efficiency-ranked, EX = exhausive search.
pure efficiency-ranked strategy, only the pure strategy was examined. The Monte Carlo strategy fares better in the unconstrained p = 2 case because the search space is smaller. Additionally, the efficiency-ranked strategy does worse against the best+1 strategy for p = 2 than it did for p = 1. This is because the effective edge deletion decreases the average indegree of the network and makes nodes easier to control indirectly. When many upstream bottlenecks are controlled, some of the down-stream bottlenecks in the efficiency-ranked list can be indirectly controlled. Thus, controlling these nodes directly results in no change in the magnetization. This gives the plateaus shown for fixing nodes 9-10 and 12-15, for example. The only case in which an exhaustive search is possible is for p = 2 with constraints, which is shown in Fig. 9 . Note that the polynomial-time best+1 strategy identifies the same set of nodes as the exponential-time exhaustive search. This is not surprising, however, since the constraints limit the available search space. This means that the Monte Carlo also does well. The efficiency-ranked method performs worst. The efficiency-ranked strategy is designed to be a heuristic strategy that scales gently, however, and is not expected to work well in such a small space when compared with more computationally expensive methods. 
B. B cell network
The B cell network was derived from the B cell interactome of Ref. [34] . The reconstruction method used in Ref. [34] removes edges from an initially complete network depending on pairwise gene expression correlation. Additionally, the original B cell network contains many protein-protein interactions (PPIs) as well as gene-gene interactions (GGIs). GGIs have definite directionality: a transcription factor encoded by one gene affects the expression level of its target gene(s). PPIs, however, do not have obvious directionality. We first filtered these PPIs by checking if the genes encoding these proteins interacted according to the PhosphoPOINT/TRANSFAC Final cancer magnetizations for a constrained search on the lung cell network using p = 2. This is the only case in which a limited exhaustive search is possible. Interestingly, the exhaustive search locates the same nodes as the best+1 strategy for fixing up to eight nodes. The efficiency-ranked strategy performs poorly compared to the Monte Carlo strategy because the search space is small and a large portion of the available space is sampled by the Monte Carlo search.
network of the previous section, and if so, kept the edge as directed. If the remaining PPIs are ignored, the results for the B cell are similar to those of the lung cell network. We found more interesting results when keeping the remaining PPIs as undirected, as is discussed below. Because of the network construction algorithm and the inclusion of many undirected edges, the B cell network is more dense (∼0.290% complete, see Table I ) than the lung cell network. This higher density leads to many more cycles than the lung cell network, and many of these cycles overlap to form one very large cycle cluster containing ∼66% of nodes in the full network. We analyzed two types of normal B cells (naïve and memory) and three types of B cell cancers (diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, and EBV-immortalized lymphoblastoma), giving six combinations in total. We present results for only the naïve/DLBCL combination below, but Tables II, III and IV list the properties of all normal/cancer combinations. The full B cell network is composed of 4364 nodes. For p = 1, there is one cycle cluster C composed of 2886 nodes. This cycle cluster has 1 ≤ n crit (C) ≤ 1460, I(C) = 4353, and 3.0 ≤ e crit (C) ≤ 4353. Finding Z(C) was deemed too difficult. Fig.10 shows the results for the unconstrained p = 1 case. Again, the pure efficiency-ranked strategy gave the same results as the mixed efficiency-ranked strategy, so only the pure strategy was analyzed. As shown in Fig. 10 , the Monte Carlo strategy is out-performed by both the efficiency-ranked and best+1 strategies. The synergistic effects of fixing multiple bottlenecks slowly becomes apparent as the best+1 and efficiency-ranked curves separate. Fig. 11 shows the results for the unconstrained p = 2 case. The largest weakly connected subnetwork contains one cycle cluster with 351 nodes, with 1 ≤ n crit ≤ 208. Although finding a set of critical nodes is difficult, the optimal efficiency for this cycle cluster is 62.2 for fixing 10 bottlenecks in the cycle cluster. This makes targeting the cycle cluster worthwhile. The efficiency of this set of 10 nodes is larger than the efficiencies of the first 10 nodes from the pure efficiency-ranked strategy, so the m c ∞ from the mixed strategy drops earlier than the pure strategy. Both strategies quickly identify a small set of nodes capable of controlling a significant portion of the differential network, however, and the same result is obtained for fixing more than 10 nodes. The best+1 strategy finds a smaller set of nodes that controls a similar fraction of the cycle cluster, and fixing more than 7 nodes results in only incremental decreases in m c ∞ . The Monte Carlo strategy performs poorly, never finding a set of nodes adequate to control a significant fraction of the nodes in the cycle cluster.
V. CONCLUSION
Signaling models for large and complex biological networks are becoming important tools for designing new therapeutic methods for complex diseases such as cancer. Even if our knowledge of biological networks is incomplete, fast progress is currently being made using reconstruction methods that use large amounts of publicly available omic data [12, 13] . The Hopfield model we use in our approach allows mapping of gene expression FIG. 11. Final cancer magnetizations for an unconstrained search on the B cell network using p = 2. The rather sudden drop in the magnetization between controlling 5 and 10 nodes in the efficiency-ranked strategies comes from flipping a significant portion of a cycle cluster. This is the only network examined in which the mixed efficiency-ranked strategy produces results different from the pure efficiency-ranked strategy.
patters of normal and cancer cells into stored attractor states of the signaling dynamics in directed networks. The role of each node in disrupting the network signaling can therefore be explicitly analyzed to identify isolated genes or sets of strongly connected genes that are selective in their action. We have introduced the concept of size k bottlnecks to identify such genes. This concept led to the formulation of several heuristic strategies, such as the efficiency-ranked and best+1 strategy to find nodes that reduce the overlap of the cell network with a cancer attractor. Using this approach, we have located small sets of nodes in lung and B cancer cells which, when forced away from their initial states with local magnetic fields (representing targeted drugs), disrupt the signaling of the cancer cells while leaving normal cells in their original state. For networks with few targetable nodes, exhaustive searches or Monte Carlo searches can locate effective sets of nodes. For larger networks, however, these strategies become too cumbersome and our heuristic strategies represent a feasible alternative. For treelike networks, the pure efficiency-ranked strategy works well, whereas the mixed efficiency-ranked strategy could be a better choice for networks with high-impact cycle clusters. Some of the genes identified in Table IV are consistent with current clinical and cancer biology knowledge. For instance, in the lung cancer list we found a well known tumor suppressor gene (TP53) [41] that is frequently mutated in many cancer types including lung cancer [42] . Mutations in PBX1 have recently been detected in nonsmall-cell lung cancer and this gene is now being consid- HNF1A  29  OR5I1  35  HNF1A  29  HMX1  41  TMEM37  22  TMEM37  25  MAP3K3  18  PBX1  38  OR5I1  20  HNF1A  23  TP53  18  MYB  25  MAP3K14  19  POSTN  21  RUNX1  17  ITGB2  20  MAP3K3  18  RORA  18  RORA  16  TNFRSF10A ered as a target for therapy and prognosis [43] . MAP3K3 and MAP3K14 are in the MAPK/ERK pathway which is a target of many novel therapeutic agents [44] , and SRC is a well known oncogene and a candidate target in lung cancer [45] . BCL6 (B-cell lymphoma 6) is the most common oncogene in DLBCL, and it is known that its expression can predict prognosis and response to drug therapy [46] . BCL6 is also frequently mutated in follicular lymphoma [47] . Our analysis identified BCL6 as an important drug target for both DLBCL and follicular lymphoma using either naive or memory B-cells as a control for both p = 1 and p = 2. RBL2 disregulation has been recently associated with many types of lymphoma [48] . FOXM1 is a potential therapeutic target in mature B cell tumors [49] and ATF2 has been recently found to be highly disregulated in lymphoma [50] . Besides BCL6 discussed above, the N/D list for DLBC contains genes (MEF2A [51] , NCOA1 [52] , TGIF1 [53] , NFATC3 [54] ) that are all known to have a functional role in cancer, even if they have not been associated to the specific Bcell cancer types we have considered. Our predictions are for the immortalized cell lines we have selected, some of which are commonly used for in-vitro testing in many laboratories. RNAi and targeted drugs could then be used in these cell lines against the top scoring genes in Table IV to test the disruption of survival or proliferative capacity. If experimentally validated, our analysis based on attractor states and bottlenecks could be applied to patient-derived cancer cells by integrating in the model patient gene expression data to identify patient-specific targets.
The above unconstrained searches assume that there exists some set of "miracle drugs" which can turn any gene "on" and "off" at will. This limitation can be patially taken into account by using constrained searches that limit the nodes that can be addressed. However, even the constrained search results are unrealistic, since most drugs directly target more than one gene. Inhibitors, for example, could target differential nodes with ξ c i = −1 and ξ n i = +1, which would damage only normal cells. Additionally, drugs would not be restricted to target only differential nodes, and certain combinations could be toxic to both normal and cancer cells. Few cancer treatments involve the use of a single drug, and the synergistic effects of combining multiple drugs adds yet another level of complication to finding an effective treatment [27] . On the other hand, the intrinsic nonlinearity of a cellular signaling network, with its inherent structure of attractor states, enhances controllability [31] so that a properly selected set of druggable targets might be sufficient for robust control.
